special subjects
Chamomile
Evidence
Limited clinical trial evidence supports any use of chamomile. However, a randomized, double-blind, placebo-controlled trial using oral capsules of chamomile extract (standardized to 1.2% apigenin) in patients with mild-to-moderate anxiety ( References ) and an open-label trial for moderate-to-severe generalized anxiety disorder ( 